Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Conference Coverage
Chemotherapy/local excision avoids proctectomy in rectal cancer
Publish date:
June 7, 2021
FROM ASCO 2021
aotto@mdedge.com
Pages
« first
1
2
Recommended Reading
Hyperprogression on immunotherapy: When outcomes are much worse
MDedge Hematology and Oncology
Success in LGBTQ+ medicine requires awareness of risk
MDedge Hematology and Oncology
The power and promise of social media in oncology
MDedge Hematology and Oncology
FDA okays upfront pembro for advanced HER2+ gastric cancer
MDedge Hematology and Oncology
Esophageal cancer: Preoperative chemoradiotherapy benefit in CROSS persists over 10 years
MDedge Hematology and Oncology
Does surgery for colorectal liver metastases release tumor cells?
MDedge Hematology and Oncology
‘Inflammasomes’ may play a role in obesity-related CRC
MDedge Hematology and Oncology
USPSTF final recommendation on CRC screening: 45 is the new 50
MDedge Hematology and Oncology
Pandemic colonoscopy restrictions may lead to worse CRC outcomes
MDedge Hematology and Oncology
Drug conjugate extends life in HER2+ end-stage metastatic colorectal cancer
MDedge Hematology and Oncology
Gastrointestinal Cancer
All Specialties
